#StemCellEvidence link to:
GVHD prophylaxis after cord blood transplantation in patients with high-risk AML: a nationwide Japanese cohort study
by Yamasaki et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
Image showing a PICO summary for: GVHD prophylaxis after cord blood transplantation in patients with high-risk AML: a nationwide Japanese cohort study by Yamasaki et al. featured in the Stem Cell Evidence Alert - February 2026
New from the #StemCellEvidence Alert:
GVHD prophylaxis after cord blood transplantation in patients with high-risk AML: a nationwide Japanese cohort study
by Yamasaki et al.
#MedSky
#StemCellEvidence link to:
Efficacy and safety of ruxolitinib for graft-versus-host disease prophylaxis in allogeneic hematopoietic stem cell transplantation: a #systematicreview and #metaanalysis
by Xie e al.
www.stemcellevidence.com/alerts/artic...
#MedSky
Image showing a PICO summary for: Efficacy and safety of ruxolitinib for graft-versus-host disease prophylaxis in allogeneic hematopoietic stem cell transplantation: a #systematicreview and #metaanalysis by Xie e al. featured in the Stem Cell Evidence Alert - February 2026
From the #StemCellEvidence Alert:
Efficacy and safety of ruxolitinib for graft-versus-host disease prophylaxis in allogeneic hematopoietic stem cell transplantation: a #systematicreview and #metaanalysis
by Xie e al.
#MedSky
Image showing a PICO summary for: Effects of rhEPO-Fc on chronic renal anemia in Chinese patients undergoing maintenance hemodialysis: a multicenter, randomized, open-label, and phase 3 study by Gan et al. Featured in the Transfusion Evidence Alert – February 2026
From the #Transfusion Evidence Alert:
Effects of rhEPO-Fc on chronic renal anemia in Chinese patients undergoing maintenance hemodialysis: a multicenter, randomized, open-label, and phase 3 study
by Gan et al.
Transfusion Evidence Library link in replies
#MedSky
#StemCellEvidence link to:
Real-world outcomes of tisagenlecleucel treatment in patients with relapsed or refractory large B-cell lymphomas: a nationwide registry
by Sakurai et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
Image showing a PICO summary for: Real-world outcomes of tisagenlecleucel treatment in patients with relapsed or refractory large B-cell lymphomas: a nationwide registry by Sakurai et al. featured in the Stem Cell Evidence Alert - February 2026
New from the #StemCellEvidence Alert:
Real-world outcomes of tisagenlecleucel treatment in patients with relapsed or refractory large B-cell lymphomas: a nationwide registry
by Sakurai et al.
#MedSky
Image showing a PICO summary for: Study of Centrifugal Therapeutic Plasma Exchange and Membrane Therapeutic Plasma Exchange; A Comparative Study by Elghoneimy et al. Featured in the Transfusion Evidence Alert – February 2026
New from the #Transfusion Evidence Alert:
Study of Centrifugal Therapeutic Plasma Exchange and Membrane Therapeutic Plasma Exchange; A Comparative Study
by Elghoneimy et al.
Transfusion Evidence Library link in replies
#MedSky
Image showing a PICO summary for: Efficacy of Desmopressin for Post-Kidney Biopsy Bleeding Complications Prevention: A Systematic Review With Frequentist and Bayesian Meta-Analysis by Chen et al. Featured in the Transfusion Evidence Alert – February 2026
From the #Transfusion Evidence Alert:
Efficacy of Desmopressin for Post-Kidney Biopsy Bleeding Complications Prevention: A Systematic Review With Frequentist and Bayesian Meta-Analysis
by Chen et al.
Transfusion Evidence Library link in the comments
#MedSky
#StemCellEvidence link to:
Modeling donor age and type trade-offs for personalized selection in allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide prophylaxis
by Mehta et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
Image showing a PICO summary for: Modeling donor age and type trade-offs for personalized selection in allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide prophylaxis by Mehta et al. featured in the Stem Cell Evidence Alert - February 2026
From the #StemCellEvidence Alert:
Modeling donor age and type trade-offs for personalized selection in allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide prophylaxis
by Mehta et al.
#MedSky
Image showing a PICO summary for: Intravenous iron for non-anaemic iron deficiency in pregnancy: a multicentre, two-arm, randomised controlled trial by Wasim et al. featured in the Transfusion Evidence Alert - February 2026
New from the #Transfusion Evidence Alert:
Intravenous iron for non-anaemic iron deficiency in pregnancy: a multicentre, two-arm, randomised controlled trial
by Wasim et al.
#MedSky
Stem Cell Evidence link to:
Re-Evaluating Donor Selection Priorities for Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide
by Mehta et al.
www.stemcellevidence.com/alerts/artic...
Image showing a PICO summary for: Re-Evaluating Donor Selection Priorities for Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide by Mehta et al. featured in the Stem Cell Evidence Alert - February 2026
New from the #StemCellEvidence Alert:
Re-Evaluating Donor Selection Priorities for Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide
by Mehta et al.
#MedSky
Image showing an extract of the Transfusion Evidence Alert - February 2026
The #Transfusion Evidence Alert is out!
Each month our clinical team picks the ten top references in the #transfusionmedicine field, each with a quick-format PICO summary, so you can rapidly identify what you need to read.
#MedSky
Image showing a PICO summary for: Donor age and type in allogeneic haematopoietic stem cell transplantation: Strong effect in MDS, limited in AML by Kim et al. featured in the Stem Cell Evidence Alert - February 2026
From the #StemCellEvidence Alert:
Donor age and type in allogeneic haematopoietic stem cell transplantation: Strong effect in MDS, limited in AML
by Kim et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
Image showing a PICO summary for: Harnessing HLA Divergence for Improved Donor Selection in Haploidentical Haematopoietic Stem Cell Transplantation by Cordeiro et al. featured in the Stem Cell Evidence Alert - February 2026
New from the #StemCellEvidence Alert:
Harnessing HLA Divergence for Improved Donor Selection in Haploidentical Haematopoietic Stem Cell Transplantation
by Cordeiro et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
Image showing a PICO summary for: How low can we go? Comparison of liberal and restrictive red cell transfusion thresholds in paediatric allogeneic haematopoietic stem cell transplantation: A randomized multicentre feasibility trial New et al. featured in the Transfusion Evidence Round-Up- International Childhood Cancer Day 2026
From the #Transfusion Evidence Round-Up- #InternationalChildhoodCancerDay 2026:
How low can we go? Comparison of liberal and restrictive red cell transfusion thresholds in paediatric (...)
New et al.
www.transfusionevidencelibrary.com/articles/402...
#MedSky
@isbt.bsky.social
Image showing a PICO summary for: RBC Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A STAR Registry Report by Inam et al. featured in the Stem Cell Evidence Alert - February 2026
From the #StemCellEvidence Alert:
RBC Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A STAR Registry Report
by Inam et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
Image showing a PICO summary for: The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations Abou Dalle et al. featured in the Stem Cell Evidence Alert - February 2026
New from the #StemCellEvidence Alert:
The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations
by Abou Dalle et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
Image showing a PICO summary for: Orca-T versus allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trial by Meyer et al. featured in the Stem Cell Evidence Alert - February 2026
From the #StemCellEvidence Alert:
Orca-T versus allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trial
by Meyer et al.
www.stemcellevidence.com/alerts/artic...
Image showing a PICO summary for: Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology Group by Huang et al. featured in the Transfusion Evidence Round-Up: International Childhood Cancer Day 2026
From the #Transfusion Evidence Round-Up- #InternationalChildhoodCancerDay 2026:
Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology Group
by Huang et al.
www.stemcellevidence.com/articles/402...
#MedSky
@isbt.bsky.social
Image showing an extract of the Stem Cell Evidence Alert - February 2026
The #StemCellEvidence monthly alert is out!
See the top 10 articles, read the PICO summaries, and subscribe to this alert here:
www.stemcellevidence.com/alerts/latest
#MedSky
Image showing a PICO summary for: Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: A study from the EBMT Acute Leukemia Working Party by Villalba et al. featured in the Stem Cell Evidence Alert - January 2026
From the #StemCellEvidence Alert:
Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: A study from the EBMT Acute Leukemia Working Party
by Villalba et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
Image showing a banner about the Talking Transfusion Podcast - International Childhood Cancer Day 2026
The #Transfusion Evidence Round-Up: #InternationalChildhoodCancerDay 2026 is out!
📄See the top articles:
www.transfusionevidencelibrary.com/alerts/latest
www.stemcellevidence.com/articles/sea...
🎙️and listen to the podcast here:
open.spotify.com/episode/4T6v...
#MedSky
@isbt.bsky.social
Image showing a PICO summary for: Comparison of Myeloablative Busulfan/Cyclophosphamide and Busulfan/Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation: A #SystematicReview and #Meta-Analysis by Shimada et al. featured in the Stem Cell Evidence Alert - January 2026
New from the #StemCellEvidence Alert:
Comparison of Myeloablative Busulfan/Cyclophosphamide and Busulfan/Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation: A #SystematicReview and #Meta-Analysis
by Shimada et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
Image showing a PICO summary for: Model-based antithymocyte globulin dosing in ex vivo CD34+ selected allogeneic haematopoietic cell transplantation: a single-centre, single-arm, phase 2 study by Scordo et al. featured in the Stem Cell Evidence Alert - January 2026
From the #StemCellEvidence Alert:
Model-based antithymocyte globulin dosing in ex vivo CD34+ selected allogeneic haematopoietic cell transplantation: a single-centre, single-arm, phase 2 study
by Scordo et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
Image showing a PICO summary for: Outcomes following matched sibling donor transplantation for severe combined immunodeficiency: a report from the PIDTC by Rayes et al. featured in the Stem Cell Evidence Alert - January 2026
New from the #StemCellEvidence Alert:
Outcomes following matched sibling donor transplantation for severe combined immunodeficiency: a report from the PIDTC
by Rayes et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
Image showing a PICO summary for: Genetic Findings of Potential Donor Origin in Cells Used for Cell and Gene Therapy: Recommendations from the World Marrow Donor Association by Pryce et al. featured in the Stem Cell Evidence Alert - January 2026
From the #StemCellEvidence Alert:
Genetic Findings of Potential Donor Origin in Cells Used for Cell and Gene Therapy: Recommendations from the World Marrow Donor Association
by Pryce et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
Image showing a PICO summary for: Non-T-Depleted Haploidentical Transplantation Compared to Allogeneic Transplantation From Matched Siblings or Unrelated Donors in Patients With Secondary AML in First Complete Remission: A Study From the ALWP/EBMT by Nagler et al. featured in the Stem Cell Evidence Alert - January 2026
New from the #StemCellEvidence Alert:
Non-T-Depleted Haploidentical Transplantation Compared to Allogeneic Transplantation From Matched Siblings or Unrelated Donors in Patients With Secondary AML in First Complete Remission (...)
by Nagler et al.
www.stemcellevidence.com/alerts/artic...
#MedSky
